Arnatar Therapeutics

Arnatar

San Diego, United States · Founded 2022 · $52.0M raised

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$52.0M
Last Round
$52.0M Series AApr 2024
Rounds
2

About

We are a San Diego-based RNA company pioneering novel therapeutics that aim to address high unmet medical needs in cardiovascular, metabolic, rare liver, kidney, and CNS diseases. Our proprietary DARGER™ platform enables both gene upregulation and downregulation using novel antisense oligonucleotide (ASO) and small interfering RNA (siRNA) approaches.

Summary

Arnatar Therapeutics is a Biotech company based in San Diego, United States, founded in 2022. It has raised $52.0M in total across 2 rounds, most recently a $52.0M Series A round in Apr 2024. Investors include Eight Roads Ventures, 3E Bioventures Capital and Apricot Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2024
$52.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arnatar Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/arnatar-therapeutics"><img src="https://indexed.vc/api/badge/company/arnatar-therapeutics" alt="Arnatar Therapeutics on Indexed.vc" width="260" height="76" /></a>